RetractedArticleCancer chemotherapy and pharmacology2022

Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway.

Peng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.